CLINICAL_TRIALS
trial_result
· 2025-02-24
Clinical Trial Update: A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis [Phase 2]
Summary
A Phase 2 clinical trial evaluating BMS-986278 in patients with pulmonary fibrosis has completed, and its results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2025-02-24